Real-time enrollment status for this glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:11 PM UTC
| NCT Number | NCT06319027 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma, IDH-Wildtype |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 18 sites in the US |
| Sponsor | ECOG-ACRIN Cancer Research Group |
| Last Updated on CT.gov | August 18, 2026 (Aug 18, 2026) |
As of October 21, 2026: Clinical trial NCT06319027 is currently recruiting participants. This phase2 study for glioblastoma, idh-wildtype is actively seeking new participants at 18 locations across the United States. The study is sponsored by ECOG-ACRIN Cancer Research Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06319027 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06319027 was last updated Aug 18, 2026 (August 18, 2026). HelloStudys verifies this status automatically.